시장보고서

상품코드

1584079

거대세포바이러스(CMV) 검사 시장 : 샘플 유형별, 약제 유형별, 검사 유형별, 최종사용자별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Cytomegalovirus (CMV) Tests Market, By Sample Type, By Drug Type, By Test Type, By End User, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 10월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 316 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

거대세포바이러스(CMV) 검사 시장 규모는 2023년에 4,990만 달러에 달하며, 2024-2032년 CAGR 1.01%로 확대

거대세포바이러스(CMV) 검사 시장 - 시장 역학

신흥 국가의 거대세포바이러스(CMV) 감염증 시장에서 치료 보급률의 상승, 바이러스에 대한 의식의 향상, 보다 효과적인 새로운 치료법의 개발이 시장 수요를 촉진

대부분의 의사들은 태아 이상이나 반복 유산이 의심되는 환자에게 세포 거대 바이러스(CMV) 검사를 권장하고 있으며, 시장 성장에 기여하고 있으며, CMV 검사는 면역력이 약한 사람이나 영유아에게 심각한 질병을 유발할 수 있는 이 바이러스를 검출하는 데 필수적입니다. CMV는 널리 퍼진 병원체로서 전 세계에서 선천성 감염의 주요 원인이며, CMV는 인간 헤르페스 바이러스의 일종으로 감염된 체액과의 친밀한 접촉, 태반 이식, 수혈, 장기 이식 등을 통해 감염되며, CMV 치료 시장은 CMV 감염 유병률 증가, 바이러스에 대한 인식 증가, 보다 효과적인 치료법 개발로 인해 성장하고 있습니다.에 대한 인식 증가, 보다 효과적인 새로운 치료법 개발 등 여러 요인에 의해 CMV 치료 시장은 성장하고 있습니다. 일반적인 CMV 치료에는 항바이러스제, 면역글로불린 요법, 줄기세포 이식 등이 있습니다. 이 시장은 또한 만성질환의 유병률 증가, 맞춤형 의료에 대한 수요, 신흥 국가의 치료 가용성 증가에 의해 주도되고 있으며, 2023년 8월National Library of Medicine이 발표 한 논문에 따르면 6 세 이상의 약 59%가 CMV에 감염되어 있으며, 혈청 유병률은 연령이 높아질수록 증가합니다. CMV 감염은 1차 감염, 재감염, 재 활성화로 나타나며 혈액제제, 수유, 밀접 접촉 환경, 주산기 감염, 성적 접촉 등 다양한 전염 경로를 통해 발생합니다. 재 활성화는 이환율과 사망률 증가를 동반하므로 면역 결핍 환자에서 특히 문제가 됩니다. 면역력이 정상인 사람이 CMV에 감염되어 사망하는 경우는 드물지만, 화학요법을 받고 있거나 코르티코스테로이드를 복용하고 있는 면역 결핍 환자에서는 심각한 건강 문제를 일으킬 수 있습니다. 골수 이식 후 CMV 관련 사망률은 10-75%로 보고되고 있으며, CMV 치료 시장을 더욱 부추기고 있습니다. 또한 CMV는 선진국의 경우 성인의 약 60-70%, 신흥 국가에서는 거의 100%가 감염되어 있습니다. 헤르페스 바이러스 중 CMV는 자연면역반응과 적응면역반응을 모두 회피하도록 특별히 설계된 유전자가 가장 많습니다. 이 바이러스는 T세포의 항원 감시를 방해하여 면역 기능 장애를 유발합니다. 또한 선천성 CMV는 학습 장애, 난청, 지적 장애의 주요 감염 요인으로 CMV 치료 시장의 중요한 촉진제가 되고 있습니다.

Cytomegalovirus(CMV) 검사 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 1.01%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

검사 유형별로는 핵산 증폭 검사(NAAT)가 22023년 가장 높은 시장 점유율을 차지했습니다.

약물 유형별로는 2023년 발칸시클로버가 주요 유형으로 부상했습니다.

지역별로는 북미가 2023년 주요 수입원으로 부상했습니다.

사이트메갈로바이러스(CMV) 검사 시장 - 세분화 분석 :

세계 CMV(Cytomegalovirus) 검사 시장은 샘플 유형, 약물 유형, 검사 유형, 최종사용자, 애플리케이션 및 지역에 따라 세분화됩니다.

검사 유형에 따라 효소 면역측정/효소 결합 면역 흡착법(EIA/ELISA), 핵산 증폭 검사(NAAT), 기타 CMV 검사로 나뉩니다. 이 중 CMV 핵산증폭검사(NAAT) 부문이 2023년 시장 점유율 1위를 차지했는데, 이는 주로 바이러스 DNA를 검출하는 민감도와 특이도가 높기 때문이며, NAAT는 특히 면역결핍 환자에서 CMV 감염을 조기에 정확하게 진단할 수 있으며, 임상현장에서 특히 유리합니다. 임상 현장에서 특히 유리합니다.

시장은 약제 유형에 따라 발간시클로버, 간시클로버, 시드호비르, 포스칼넷, 기타 등 5가지 범주로 분류됩니다. 거대세포바이러스(CMV) 검사 시장에서는 발간시클로버가 주요 약물 유형으로 눈에 띕니다. 그 주요 이유는 경구 생체 이용률과 특히 면역 결핍 환자의 CMV 감염 예방 및 치료 효과 때문입니다. 간시클로버와 같은 정맥 투여에 비해 투여가 용이해 임상 현장에서 인기가 높아지고 있습니다. 특히 급성기에는 여전히 간시클로버가 중요하며, 내성 환자의 경우 시드호비르, 포스칼넷과 같은 다른 약물이 사용되지만, 발간시클로버의 입증된 효과와 간편한 투여 방법으로 인해 의료 전문가들 사이에서 발간시클로버가 선호되고 있습니다. 선호되고 있습니다. 이러한 추세는 CMV 감염 관리에 있으며, 보다 환자 중심의 치료 솔루션을 향한 광범위한 움직임을 강조합니다.

Cytomegalovirus(CMV) 검사 시장 - 지역적 인사이트

북미는 거대세포바이러스(CMV) 검사 시장의 주요 지역입니다. 그 주요 이유는 높은 수준의 의료 인프라, 항생제 내성 감염의 높은 유병률, 연구개발에 대한 막대한 투자 때문입니다. 이 지역의 병원들은 MRSA와 같은 심각한 그람양성균 감염을 관리하기 위해 항생제, 특히 반코마이신을 대량으로 소비하고 있습니다. 또한 규제 프레임워크와 감염 관리에 대한 강조는 거대세포바이러스(CMV) 검사에 대한 수요 증가에 기여하고 있습니다. 이 지역에는 주요 제약회사들이 존재하고 임상시험이 진행 중이기 때문에 시장 리더십이 더욱 강화되고 있습니다.

Cytomegalovirus(CMV) 검사 시장 - 경쟁 구도 :

CMV 검사 시장의 기업은 시장 입지를 강화하고 혁신을 촉진하기 위해 다양한 전략을 채택하고 있습니다. 주요 초점은 검사 방법의 민감도와 특이성을 높이고 신속한 진단 솔루션을 개발하기 위한 연구개발에 투자하는 것입니다. 의료 서비스 프로바이더 및 검사 시설과의 협력은 검사 프로세스를 간소화하고 임상적 요구에 대한 인사이트을 수집하는 데 도움이 됩니다. 마케팅 활동은 의료 전문가와 의료기관을 대상으로 CMV 관련 질환의 조기 발견과 관리의 중요성을 강조하고 있습니다. 또한 각 회사는 CMV의 위험에 대한 인식을 높이기 위한 교육 캠페인을 통해 검사 제품 및 서비스 시장을 확대하기 위해 노력하고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제13장 주요 벤더 분석 - 거대세포바이러스(CMV) 검사 업계

경쟁 대시보드
기업 개요
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- F. Hoffmann-La Roche Ltd.
- Zydus Cadila
- Lupin
- Cipla Inc.
- Aurobindo Pharma
- Glenmark Pharmaceuticals Limited
- Endo International plc
- AstraZeneca
- Johnson & Johnson Private Limited
- Bio-Rad Laboratories, Inc.
- BD
- 기타

제14장 애널리스트의 전방위 전망

KSA 24.11.18

REPORT HIGHLIGHT

Cytomegalovirus (CMV) Tests Market size was valued at USD 49.90 Million in 2023, expanding at a CAGR of 1.01% from 2024 to 2032.

Cytomegalovirus (CMV) tests are diagnostic tools designed to identify the presence of CMV, a widespread virus that can lead to serious health complications, particularly in immunocompromised individuals and newborns. These tests often utilize laboratory techniques, including polymerase chain reaction (PCR) for detecting viral DNA, as well as serological methods to identify the antibodies against CMV. Early detection is vital for managing potential complications, such as congenital CMV infection in infants or opportunistic infections in transplant recipients. Accurate testing enables timely intervention and monitoring, making CMV testing a critical aspect of healthcare for at-risk populations.

Cytomegalovirus (CMV) Tests Market- Market Dynamics

Increasing incidence prevalence of the CMV infections, increased awareness about virus, and the development of new and more effective treatment options to propel market demand

Most physicians recommend cytomegalovirus (CMV) tests for patients with suspected fetal abnormalities or recurrent miscarriages, contributing to market growth. CMV tests are essential for detecting this virus, which can lead to serious illnesses in immunocompromised individuals and infants. As a widely distributed pathogen, CMV is the leading cause of congenital infections globally. It is a human herpesvirus that can be transmitted through intimate contact with infected bodily fluids, as well as via transplacental transfer, blood transfusions, or organ transplants. The CMV treatment market is propelled by several factors, including the rising prevalence of CMV infections, increased awareness about the virus, and the development of new and more effective treatment options. Common CMV treatments include antiviral medications, immunoglobulin therapy, and stem cell transplantation. This market is further driven by the growing incidence of chronic diseases, the demand for personalized medicine, and the increasing availability of treatments in developing countries. According to an August 2023 article published by the National Library of Medicine, approximately 59% of individuals over six years old have encountered CMV, with seroprevalence increasing with age. CMV infections can manifest as primary infections, reinfections, or reactivations, occurring through various transmission modes such as blood products, breastfeeding, close-contact settings, perinatal transmission, and sexual contact. Reactivation is particularly concerning in immunocompromised patients, as it is associated with increased morbidity and mortality. For individuals with intact immunity, CMV rarely results in death; however, in immunocompromised patients undergoing chemotherapy or taking corticosteroids, it can lead to significant health issues. Following bone marrow transplants, reported mortality rates related to CMV vary between 10% and 75%, further boosting the CMV treatment market. Moreover, CMV infects approximately 60% to 70% of adults in industrialized countries and nearly 100% in emerging countries. Among herpesviruses, CMV has the largest number of genes specifically designed to evade both innate and adaptive immune responses. This virus poses a burden on T-cell antigenic surveillance and contributes to immune dysfunction. Additionally, congenital CMV is a primary infectious cause of learning disabilities, deafness, and intellectual disabilities, making it a significant driver for the CMV treatment market.

Cytomegalovirus (CMV) Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 1.01% over the forecast period (2024-2032)

Based on Test Type segmentation, nucleic acid amplification tests (NAATs) was predicted to show maximum market share in the year 2023

Based on Drug Type segmentation, Valganciclovir was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Cytomegalovirus (CMV) Tests Market- Segmentation Analysis:

The Global Cytomegalovirus (CMV) Tests Market is segmented on the basis of Sample Type, Drug Type, Test Type, End User, Application, and Region.

The market is divided into three categories based on Test Type: enzyme immunoassay/enzyme-linked immunosorbent assay (EIA/ELISA) tests, nucleic acid amplification tests (NAATs), and other CMV tests. Among these, the CMV nucleic acid amplification tests (NAATs) segment led the market share in 2023, primarily due to their high sensitivity and specificity in detecting viral DNA. NAATs are particularly advantageous in clinical settings because they enable early and accurate diagnosis of CMV infections, especially in immunocompromised patients, where timely intervention is critical to preventing severe complications.

The market is divided into five categories based on Drug Type: Valganciclovir, Ganciclovir, Cidofovir, Foscarnet and Others. In the cytomegalovirus (CMV) tests market, Valganciclovir stands out as the leading drug type, largely due to its oral bioavailability and effectiveness in preventing and treating CMV infections, especially in immunocompromised patients. Its ease of administration compared to intravenous alternatives like Ganciclovir enhances its popularity in clinical settings. Although Ganciclovir remains significant, particularly in acute situations, and other medications such as Cidofovir and Foscarnet are employed for resistant cases, Valganciclovir's proven efficacy and user-friendly administration make it the preferred option among healthcare professionals. This trend underscores a wider movement toward more patient-centric treatment solutions in managing CMV infections.

Cytomegalovirus (CMV) Tests Market- Geographical Insights

North America is the dominating region in the Cytomegalovirus (CMV) Tests market, primarily due to its advanced healthcare infrastructure, high prevalence of antibiotic-resistant infections, and significant investments in research and development. The region's hospitals are major consumers of these antibiotics, particularly Vancomycin, to manage serious Gram-positive infections like MRSA. Furthermore, supportive regulatory frameworks and a strong emphasis on infection control contribute to the growing demand for Cytomegalovirus (CMV) Tests. The presence of key pharmaceutical companies and ongoing clinical trials in this region further enhance its market leadership.

Cytomegalovirus (CMV) Tests Market- Competitive Landscape:

Companies in the CMV tests market adopt various strategies to strengthen their market presence and foster innovation. A primary focus is on investing in research and development to enhance the sensitivity and specificity of testing methods while creating rapid diagnostic solutions. Collaborations with healthcare providers and laboratories help streamline testing processes and gather insights into clinical needs. Marketing initiatives highlight the significance of early detection and management of CMV-related conditions, targeting healthcare professionals and institutions. Additionally, companies engage in educational campaigns to raise awareness about CMV risks, thereby expanding the market for their testing products and services.

Recent Developments:

In September 2022, ProBioGen entered into an agreement with the City of Hope to manufacture the CMV vaccine for clinical trials and commercial distribution, accelerating the development and production of the vaccine that could potentially save numerous lives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
F. Hoffmann-La Roche Ltd.
Zydus Cadila
Lupin
Cipla Inc.
Aurobindo Pharma
Glenmark Pharmaceuticals Limited
Endo International plc
AstraZeneca
Johnson & Johnson Private Limited
Bio-Rad Laboratories, Inc.
BD
Others

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

Urine
Blood

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

Valganciclovir
Ganciclovir
Cidofovir
Foscarnet
Others

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

Enzyme immunoassay/enzyme-linked immunosorbent assay (EIA/ELISA) tests
Nucleic acid amplification tests (NAATs)
Other CMV tests

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Diagnostic Centres
Clinics
Others

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Retinitis
Pneumonia
Gastrointestinal ulcers
Encephalitis
Stem cell transplantation
Organ transplantation
Others (Mouth Ulcers, Pharyngitis, etc.)

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Cytomegalovirus (CMV) Tests Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cytomegalovirus (CMV) Tests Market Snippet by Sample Type
- 2.1.2. Cytomegalovirus (CMV) Tests Market Snippet by Drug Type
- 2.1.3. Cytomegalovirus (CMV) Tests Market Snippet by Test Type
- 2.1.4. Cytomegalovirus (CMV) Tests Market Snippet by End User
- 2.1.5. Cytomegalovirus (CMV) Tests Market Snippet by Application
- 2.1.6. Cytomegalovirus (CMV) Tests Market Snippet by Country
- 2.1.7. Cytomegalovirus (CMV) Tests Market Snippet by Region
2.2. Competitive Insights

3. Cytomegalovirus (CMV) Tests Key Market Trends

3.1. Cytomegalovirus (CMV) Tests Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cytomegalovirus (CMV) Tests Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cytomegalovirus (CMV) Tests Market Opportunities
3.4. Cytomegalovirus (CMV) Tests Market Future Trends

4. Cytomegalovirus (CMV) Tests Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cytomegalovirus (CMV) Tests Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Cytomegalovirus (CMV) Tests Market Landscape

6.1. Cytomegalovirus (CMV) Tests Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cytomegalovirus (CMV) Tests Market - By Sample Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
- 7.1.2. Urine
- 7.1.3. Blood

8. Cytomegalovirus (CMV) Tests Market - By Drug Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
- 8.1.2. Valganciclovir
- 8.1.3. Ganciclovir
- 8.1.4. Cidofovir
- 8.1.5. Foscarnet
- 8.1.6. Others

9. Cytomegalovirus (CMV) Tests Market - By Test Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
- 9.1.2. Enzyme immunoassay/enzyme-linked immunosorbent assay (EIA/ELISA) tests
- 9.1.3. Nucleic acid amplification tests (NAATs)
- 9.1.4. Other CMV tests

10. Cytomegalovirus (CMV) Tests Market - By End User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Diagnostic Centres
- 10.1.4. Clinics
- 10.1.5. Others

11. Cytomegalovirus (CMV) Tests Market - By Application

11.1. Overview
- 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 11.1.2. Retinitis
- 11.1.3. Pneumonia
- 11.1.4. Gastrointestinal ulcers
- 11.1.5. Encephalitis
- 11.1.6. Stem cell transplantation
- 11.1.7. Organ transplantation
- 11.1.8. Others (Mouth Ulcers, Pharyngitis, etc.)

12. Cytomegalovirus (CMV) Tests Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Cytomegalovirus (CMV) Tests Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Cytomegalovirus (CMV) Tests Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Cytomegalovirus (CMV) Tests Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Cytomegalovirus (CMV) Tests Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Cytomegalovirus (CMV) Tests Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Cytomegalovirus (CMV) Tests Industry

13.1. Competitive Dashboard
13.2. Company Profiles
- 13.2.1. Pfizer Inc.
- 13.2.2. GlaxoSmithKline plc
- 13.2.3. Novartis AG
- 13.2.4. Mylan N.V.
- 13.2.5. Teva Pharmaceutical Industries Ltd.
- 13.2.6. Sanofi
- 13.2.7. F. Hoffmann-La Roche Ltd.
- 13.2.8. Zydus Cadila
- 13.2.9. Lupin
- 13.2.10. Cipla Inc.
- 13.2.11. Aurobindo Pharma
- 13.2.12. Glenmark Pharmaceuticals Limited
- 13.2.13. Endo International plc
- 13.2.14. AstraZeneca
- 13.2.15. Johnson & Johnson Private Limited
- 13.2.16. Bio-Rad Laboratories, Inc.
- 13.2.17. BD
- 13.2.18. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us